{
    "title": "Valneva targets 2022 revenue boost on COVID-19 vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10471503/Valneva-targets-2022-revenue-boost-COVID-19-vaccine.html",
    "date": "2022-02-03",
    "keywords": [
        "vaccine",
        "company",
        "year",
        "covid19",
        "valneva",
        "vla2001",
        "deal",
        "supply",
        "contract",
        "developer",
        "candidate",
        "euros",
        "revenue",
        "subject",
        "drug",
        "regulator",
        "review",
        "valnevas",
        "inactivatedvirus",
        "eu",
        "phase",
        "change",
        "biotechs",
        "finance",
        "chief",
        "peter",
        "buehler",
        "statement",
        "agreement",
        "companys",
        "britain",
        "government",
        "breach",
        "health",
        "secretary",
        "sajid",
        "javid",
        "country",
        "cash",
        "position",
        "nasdaq",
        "listing",
        "end",
        "december",
        "news",
        "price",
        "november",
        "piotr",
        "lipinski",
        "gdansk",
        "editing",
        "schmollinger",
        "gerry",
        "doyle"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}